The European Commission is preparing an amending act proposing to introduce new hazard classes for endocrine disruptors in the CLP Regulation (EC No. 1272/2008). Within one year of the entry into force of the amending act, the EU Commission shall ask European Chemicals Agency (ECHA) to assess whether resorcinol meets the class of endocrine disruptors and whether it should be identified as a substance of very high concern (SVHC).

The Committee for Risk Assessment (RAC) has adopted opinions and amendments to Annex VI to the CLP regulation, with 39 new entries added, 17 entries amended and 1 entry deleted. This amended Regulation shall enter into force on May 3, 2022, and will be implemented from November 23, 2023.